Welcome to Strama - the Swedish strategic programme against antibiotic resistance.
Council Conclusions on innovative incentives for effective Antibiotics
At the EU Minister of Health meeting on 1 December the Council adopted conclusions as a result of the conference " Innovative Incentives for Effective Antibacterials"
A Report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine, published by Strama and The Swedish Institute for Infectious Disease Control. Announced June 10th 2009.
Fact Sheets on the Burden of Antibiotic Resistance
The Burden of Antibiotic Resistance in several areas of healthcare is discussed in fact sheets published by ReAct, the worldwide network for action on antibiotic resistance.
European recommendations on healthcare associated infections
The Commission has adopted a proposal for Council recommendations on patient safety. Healthcare associated infections are mentioned as an example of preventable injuries. Systematic efforts including education and improved reporting are methods that have proven efficient.
The first-ever European Antibiotic Awareness Day will be celebrated in 27 EU member states. In Sweden, Strama is launching a campaign with information and advice about common colds. The message is: Take care, not antibiotics!
Annual Report 2007
Strama's annual report summarizes publications, projects, and other activities in 2007. Click to download in pdf.
We are facing a global pandemic of antibiotic resistance, warn experts
Vital components of modern medicine such as major surgery, organ transplantation, and cancer chemotherapy will be threatened if antibiotic resistance is not tackled urgently, warn experts on bmj.com today.
A Report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine, published by Strama and The Swedish Institute for Infectious Disease Control. Announced June 10th 2008.
Sweden has the lowest use of antibiotics in the Nordic countries, but the use of quinolones is still high
In Sweden and Norway, the use of antibiotics has increased steadily during the last three years. In Denmark, the increase has been going on for a longer period. Among the Nordic countries, Sweden still has the lowest total use. However, we have the second highest use of fluoroquinolones, following Finland. Click on "Read more" for statistics!
ESBL resistance in enteric bacteria - proposed action plan
Strama has taken the initiative in creating a national strategy against ESBL resistance, containing diagnosis, epidemiological typing and antibiotic recommendations.
The Antibiotic Innovation Study: Expert Voices on a Critical Need
In a report published by the international network React (Action on antibiotic resistance) public health and industry experts conclude that urgent action is needed to tackle the lack of research and development into new antibiotics.
På svenska
